Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials.
Christian LamplViktoria KrausKatrina LehnerBrett LoopMahan ChehrenamaZofia MaczynskaShannon RitterJan KlattJosefin SnellmanPublished in: The journal of headache and pain (2022)
ClinicalTrials.gov Identifiers: NCT02066415, NCT02456740, NCT02483585, NCT03096834, NCT03333109.